Singapore: Researchers in Singapore have developed a new protein that can alter DNA in living cells with much higher pre...
Glenmark Pharmaceuticals USA (Glenmark) has been granted final approval by the United States Food & Drug Administrat...
Singapore: Australian company Novogen, engaged in a pilot program aimed at breakthrough development of drugs to treat a ...
Singapore: Glenmark Pharmaceuticals has started the discovery and initiation of IND enabling studies of a novel clinical...
Singapore: Investigational agent, tivozanib, has demonstrated statistically significant and clinically meaningful PFS su...
Pluristem Therapeutics Inc., Israel's developer of placenta-based cell therapy products, has reached an agreement with J...
Singapore: Australia-based Bone Medical, a biopharmaceutical company focused on the development of new medicines for mus...
Singapore: The US FDA's Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has voted unanimously in support o...
Japanese pharmaceutical giant Chugai Pharmaceutical Co Ltd has announced that its Actemra Subcutaneous Injection (Actemr...
Prosetta Biosciences Inc. has entered into a Feasibility and First Right of Negotiation Agreement with Japan's Takeda Ph...
Pharma Major Lupin announced that its US subsidiary, Gavis Pharmaceuticals LLC., (collectively Lupin) has received final...
Singapore: GlobalData's analysis shows that the global gout therapeutics market grew at a compound annual growth rate (...
Singapore: US-based Repligen has entered into an exclusive worldwide licensing agreement with Pfizer to advance Repligen...
Singapore: United Kingdom (UK) has committed to contrbute $1.6 billion to fight AIDS, Tuberculosis and Malaria. Ms Just...
Singapore: China based biotech firm developing targeted and immune-oncology therapeutics, BeiGene, has raised $75 millio...
Singapore: Johns Hopkins University's Institute for Applied Economics, Global Health and the Study of Business Enterpris...
Bangalore: Suven Life Sciences received three product patents one each from Canada (2600271), China (CN 101544592B) and ...
Singapore: US Food and Drug Administration has raised alarm for Gilead Science's cancer medicine Zydelig (idelalisib) du...
